Cost effectiveness of roxithromycin versus cefaclor in Australia.
Scott
W G
WG
Cooper
B C
BC
Scott
H M
HM
Tilyard
M W
MW
Dovey
S M
SM
D001315:Australia; D002433:Cefaclor / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D005500:Follow-Up Studies; D006801:Humans; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000191:economics; D015575:Roxithromycin / Q000191:economics* / Q000627:therapeutic use; D016896:Treatment Outcome